International Journal of Molecular Sciences· 2026Q1· Review
Eating Behavior in Menopausal Women: From Molecular to Clinical Aspects—What Changes?
- 0citations
- Q1SCImago
- 2026year
Short summary
Estrogen deficiency during menopause disrupts hypothalamic appetite regulation via ERα/ERβ, altering neuropeptides (NPY, AgRP, POMC) and peripheral signals (leptin, ghrelin, insulin), leading to increased appetite, cravings, and a 2-3 kg average weight gain with preferential visceral fat accumulation.
AI-generated from the title and abstract; the full text is not read.
Key points
- Estrogen deficiency during menopause dysregulates hypothalamic appetite control via ERα/ERβ.
- Key neuropeptides (NPY, AgRP, POMC) and peripheral signals (leptin, ghrelin, insulin) are altered.
- Postmenopausal women experience increased appetite, carbohydrate cravings, and heightened food reward.
- Menopause transition leads to average 2-3 kg weight gain, with preferential visceral fat accumulation (44% increase) and sarcopenia.
AI-generated from the title and abstract; the full text is not read.
Abstract
The menopausal transition represents a critical period in women’s lives characterized by profound hormonal, metabolic, and behavioral changes. Estrogen deficiency during menopause triggers complex alterations in eating behavior through multiple molecular mechanisms involving hypothalamic neuropeptide systems, neurotransmitter pathways, and peripheral hormonal signals. This narrative review examines the molecular basis of eating behavior changes in menopausal women, integrating evidence from basic science and clinical research. At the molecular level, declining estradiol disrupts the hypothalamic regulation of appetite through estrogen receptors ERα and ERβ, leading to dysregulation of key neuropeptides including neuropeptide Y (NPY), agouti-related peptide (AgRP), and proopiomelanocortin (POMC). Peripheral signals such as leptin, ghrelin, and insulin show altered secretion and sensitivity patterns. Clinically, postmenopausal women experience increased appetite, heightened food reward sensitivity, carbohydrate cravings, and elevated risk of binge eating behaviors. These changes contribute to weight gain averaging 2–3 kg during the menopausal transition, with preferential visceral fat accumulation increasing metabolic syndrome risk. Body composition shifts include 44% increases in visceral adiposity and concurrent sarcopenia. Emerging evidence highlights the role of gut microbiota alterations in mediating metabolic dysfunction. Therapeutic strategies including hormone replacement therapy, targeted nutritional interventions, and lifestyle modifications show promise in mitigating these changes. Understanding the molecular-to-clinical continuum of eating behavior changes in menopause is essential for developing evidence-based preventive and therapeutic approaches to improve metabolic health and quality of life in postmenopausal women.
The authors' abstract, as published at the source. International Journal of Molecular Sciences, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Endocrine and Autonomic Systems
Endocrine and Autonomic SystemsNeuroscience